4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial Infarction Prasugrel, Ticagrelor - Myocardial Infarction, Angioplasty, Balloon, Coronary | Phase 4 | Completed | Faculty Hospital Kralovske Vinohrady | 1226 | 2013-01-01 | 2017-08-11 |
| ACCEL-LOADING-ACS Study Dual Anti-Platelet Therapy (DAPT), Triple Anti-Platelet Therapy (TAPT) - Platelet Aggregation Inhibitors, Anti-inflammatory Agent | Phase 4 | Completed | Gyeongsang National University Hospital | 220 | 2010-07-01 | 2013-09-24 |
| WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing) PCI (percutaneous coronary intervention) - Anticoagulants, Platelet Aggregation Inhibitors | Phase 4 | Completed | R&D Cardiologie | 573 | 2008-12-01 | 2013-01-15 |
| Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) Clopidogrel, Aspirin - Platelet Aggregation Inhibitors, Coronary Heart Disease | Phase 4 | Completed | University of Maryland, Baltimore | 682 | 2006-07-01 | 2022-02-24 |
Atrial Fibrillation (1) · Coronary Disease (1) · Inflammation (1) · Myocardial Infarction (1) · Myocardial Reperfusion Injury (1)
Cardiovascular Diseases (4) · Heart Diseases (4) · Myocardial Ischemia (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Vascular Diseases (3) · Arrhythmias, Cardiac (1) · Cardiomyopathies (1) · Infarction (1) · Ischemia (1) · Necrosis (1) · Postoperative Complications (1) · Reperfusion Injury (1)
Aspirin (1) · Clopidogrel (1) · Dual Anti-Platelet Therapy (1) · Percutaneous Coronary Intervention (1) · Prasugrel Hydrochloride (1) · Ticagrelor (1)
Faculty Hospital Kralovske Vinohrady (1) · Gyeongsang National University Hospital (1) · R&D Cardiologie (1) · University of Maryland, Baltimore (1)
Belgium (1) · Czechia (1) · Netherlands (1) · South Korea (1) · United States (1)
Alan R. Shuldiner, MD (1) · Jae-Hyeong Park, MD, PhD (1) · Jon Suh, MD, PhD (1) · Keun-Ho Park, MD (1) · Kyounghoon Lee, MD, PhD (1) · Petr Widimsky, Prof MD DrSc (1) · Sang-Yong Yoo, MD, PhD (1) · Zuzana Motovska, MD PhD (1)
PMID 17394957, PMID 19706858, PMID 19853687, PMID 20118150, PMID 21881565, PMID 23111421, PMID 23392654, PMID 23415013, PMID 23809542, PMID 24970794, PMID 26374108, PMID 27799230, PMID 29154813, PMID 29653637
U01GM074518 (1)